Natural Products in Drug Discovery: Recent Advances

Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives

Volumn , Issue , 2012, Pages 1-42

  Cragg, Gordon M ^a   Grothaus, Paul G ^a   Newman, David J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Combinatorial biosynthesis, screening of libraries; HTS screening of compounds, in drug discovery; Microbial diversity, the unexplored potential; Microorganismal role in drug discovery; Natural products in drug discovery, recent advances

Indexed keywords

EID: 84886148029     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118260005.ch1     Document Type: Chapter

References (238)

1. Borchardt, J.K. (2002). The beginnings of drug therapy: Ancient Mesopotamian medicine. Drug News Perspective, 15, 187-192.
2. Huang, K.C., The Pharmacology of Chinese Herbs, CRC Press, Boca Raton, FL, 1999.
3. Kapoor, L.D., CRC Handbook of Ayurvedic Medicinal Plants, CRC Press, Boca Raton, FL, 1990.
4. Dev, S. (1999). Ancient-modern concordance in Ayurvedic plants: Some examples. Environmental Health Perspectives, 107, 783-789.
5. Johnson, T., CRC Ethnobotany Desk Reference, CRC Press, Boca Raton, FL, 1999.
6. Moerman, D.E., Medicinal Plants of Native America, Vol. 1, University of Michigan Museum of Anthropology, Ann Arbor, MI, 1986.
7. Farnsworth, N.R., Akerele, R.O., Bingel, A.S., Soejarto, D.D., Guo, Z. (1985). Medicinal plants in therapy. Bulletin of the World Health Organization, 63, 965-981.
8. Fabricant, D.S., Farnsworth, N.R. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109, 69-75.
9. Buss, A.D., Waigh, R.D., Natural products as leads for new pharmaceuticals. In: Wolff, M.E. editor. Burger's Medicinal Chemistry and Drug Discovery. Principles and Practice, 5th ed., John Wiley & Sons, Inc., New York, 1995, pp. 983-1033.
10. Wongsrichanalai, C., Pickard, A.L., Wernsdorfer, W.H., Meshnick, S.R. (2002). Epidemiology of drug-resistant malaria. Lancet Infectious Diseases, 2, 209-218.
11. Klayman, D.L. (1985). Qinghaosu (artemisinin): An antimalarial drug from China. Science, 228, 1049-1055.
12. O'Neill, P.M., Posner, G.H. (2004). A medicinal chemistry perspective on artemisinin and related endoperoxides. Journal of Medicinal Chemistry, 47, 2945-2964.
13. Vennerstrom, J.L., Arbe-Barnes, S., Brun, R., Charman, S.A., Chiu, F.C.K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., McIntosh, K., Padmanilayam, M., Santo Tomas, J., Scheurer, C., Scorneaux, B., Tang,Y., Urwyler, H., Sergio,W., Charman,W.N. (2004). Identification of an antimalarial synthetic trioxolane drug development candidate. Nature, 430, 900-904.
14. Posner, G.H., Chang, W., Hess, L., Woodard, L., Sinishtaq, S., Usera, A.R., Miao, W., Rosenthal, A.S., Kalinda, A.S., D'Angelo, J.G., Petersen, K.S., Stohler, R., Chollet, J., Santo-Tomas, J., Snyder, C., Rottmann, M., Wittlin, S., Brun, R., Shapiro, T.A. (2008). Malaria-infected mice are cured by oral administration of new artemisinin derivatives. Journal of Medicinal Chemistry, 51, 1035-1042.
15. Nagelschmitz, J., Voith, B., Wensing, G., Roemer, A., Fugmann, B., Kotecka, B.M., Rieckmann, K.H., Edstein, M.D. (2008). First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrobial Agents and Chemotherapy, 52, 3085-3091.
16. Dondorp, A.M., Nosten, F.,Yi, P., Das, D., Phyo, A.P., Tarning, J., Lwin, K.M., Ariey, F., Hanpithakpong,W., Lee, S.J., Ringwald, P., Silamut, K., Imwong, M., Chotivanich, K., Lim, P., Herdman, T., An, S.S., Yeung, S., Singhasivanon, P., Day, N.P., Lindegardh, N., Socheat, D., White, N.J. (2009). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361, 455-467. Erratum in: New England Journal of Medicine, 361, 1714.
17. Eastman, R.T., Fidock, D.A. (2009). Artemisinin-based combination therapies: Vital tool in efforts to eliminate malaria. Nature Reviews Microbiology, 7, 864-874.
18. Cui, L., Su, X.Z. (2009). Discovery, mechanisms of action and combination therapy of artemisinin. Expert Review of Anti-Infective Therapy, 7, 999-1013.
19. Keasling, J.D. (2008). Synthetic biology for synthetic chemistry. ACS Chemical Biology, 3, 64-76.
20. Tsuruta, H., Paddon, C.J., Eng, D., Lenihan, J.R., Horning, T., Anthony, L.C., Regentin, R., Keasling, J.D., Renninger, N.S., Newman, J.D. (2009). High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PloS One, 4, e4489.
21. Hartwell, J.L., Plants Used Against Cancer, Quarterman, Lawrence, MA, 1982.
22. Cragg, G.M., Boyd, M.R., Cardellina, J.H.,Newman, D.J., Snader, K.M., McCloud,T.G., Ethnobotany and drug discovery: The experience of the US National Cancer Institute. In: Chadwick, D.J., Marsh, J., editors. Ethnobotany and the Search for New Drugs, Vol. 185, John Wiley & Sons, Inc., Ciba Foundation Symposium, New York, 1994, pp. 178-196.
23. Cragg, G.M., Newman, D.J. (2009). Nature: Avital source of leads for anticancer drug development. Phytochemistry Reviews, 8, 313-331.
24. Cragg, G.M., Grothaus, P.G., Newman, D.J. (2009). Impact of natural products on developing new anti-cancer agents. Chemical Reviews, 109, 3012-3043.
25. Margulis L, Schwartz KV, Five Kingdoms: An Illustrated Guide to the Phyla of Life on Earth, W. H. Freeman & Co., New York, 1988.
26. Molinski, T.F., Dalisay, D.S., Lievens, S.L., Saludes, J.P. (2009). Drug development from marine natural products. Nature Reviews Drug Discovery, 8, 69-85.
27. Wallace, M.S. (2006) Ziconotide: A new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Review of Neurotherapeutics, 6, 1423-1428.
28. Bulaj, G., Buczek, O., Goodsell, I., Jiminez, E.C., Kranski, J., Nielsen, J.S., Garrett, J.E., Olivera, B.M. (2003). Efficient oxidative folding of conotoxins and the radiation of venomous cone snails. Proceedings of the National Academy of Sciences of the USA, 100, 14562-14568.
29. TM;Aplidine, and Kahalalide F. In: Cragg, G.M.,Kingston, D.G.I., andNewman,D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 215-240.
30. Yu, M.J., Kishi, Y., Littlefield, B.A., Discovery of E7389, a fully synthetic macrocyclic ketone analog of halichondrin B. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 241-265.
31. Newman, D.J., The bryostatins. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, 2005, pp. 137-150.
32. Twelves, C., Loesch, D., Blum, J.L., Vahdat, L.T., Petrakova, K., Chollet, P.J., Akerele, C.E., Seegobin, S., Wanders, J., Cortes, J. (2010). A phase III study (EMBRACE) of eribulin mesylate versus treatment of physician's choice in patients with locally recurrent or metastatic breast cancer previously treated with an anthracycline and a taxane. 2010 ASCO Annual Meeting. Journal of Clinical Oncology, 28, 18s.
33. Scriabine, A., Discovery and development of major drugs.Currently in use. In: Landau, R., Achilladelis, B., and Scriabine, A.editors. Pharmaceutical Innovation. Revolutionizing Human Health, Chemical Heritage Press, Philadelphia, 1999, pp. 148-270.
34. Arcamone, F.M., Anthracyclines. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 299-320.
35. Hecht, S.M., Bleomycin group antitumor agents. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 357-381.
36. Remers, W.A., The mitomycins. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 475-497.
37. Hamann, P.R., Upeslacis, J., and Borders, D.B., Enediynes. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 451-474.
38. Prudhomme, M., Staurosporines and structurally related indolocarbazoles as antitumor agents. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J.editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 499-517.
39. Hofle, G., Reichenbach, H., Epothilone, a myxobacterial metabolite with promising antitumor activity. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 413-450.
40. Daly, J.W., Spande, T.F., Garrafo, H.M. (2005). Alkaloids from amphibian skins. A tabulation of over eight hundred compounds. Journal of Natural Products, 68, 1556-1575.
41. Eng, J., Kleinman,W.A., Singh, G., Raufman, J.P. (1992). Isolation and characterization of Exendin-4, an Exendin-3 analogue from Heloderma suspectum venom. Journal of Biological Chemistry, 267, 7402-7405.
42. Newman, D.J., Cragg, G.M. (2007). Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70, 461-477.
43. Cragg, G.M., Newman, D.J. Natural product sources of drugs: Plants, microbes, marine organisms and animals. In: Kennewell, P.D., Triggle, D., and Taylor, J. editors. Comprehensive Medicinal Chemistry II, Vol. 1 Elsevier, Oxford, 2006, pp. 355-403.
44. Balandrin, M.F., Kinghorn, A.D., Farnsworth, N.R., Plant-derived natural products in drug discovery and development: An overview. In: Kinghorn, A.D., and Balandrin, M.F. editors. Human Medicinal Agents from Plants, Vol. 534 American Chemical Society, Washington, DC, 1993, pp. 2-12.
45. Raskin, I., Ribnicky, D.M., Komarnytsky, S., Ilic, N., Poulev, A., Borisjuk, N., Brinker, A., Moreno, D.A., Ripoll, C., Yakoby, N., O'Neal, J. M., Cornwell, T., Pastor, I., Fridlander, B. (2002). Plants and human health in the twenty-first century. Trends in Biotechnology, 20, 522-531.
46. Newman, D.J., Hill, R.T. (2006). New drugs from marine microbes: The tide is turning. Journal of Industrial Microbiology Biotechnology, 33, 539-544.
47. Perry, N.B., Ettouati, L., Litaudon, M., Blunt, J.W., Munro, M.H.G. (1994). Alkaloids from the antarctic sponge Kirkpatrickia varial. Part 1: Variolin B, a new antitumour and antiviral compound. Tetrahedron, 50, 3987-3992.
48. Trimurtulu, G., Faulkner, D.J., Perry, N.B., Ettouati, L., Litaudon, M., Blunt, J.W., Munro, M.H.G., Jameson, G.B. (1994). Alkaloids from the antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin A and N(30)-methyl tetrahydrovariolin B. Tetrahedron, 50, 3993-4000.
49. Diyabalanage, T., Amsler, C.D., McClintock, J.B., Baker, B.J. (2006). Palmerolide A, a cytotoxic macrolide from the antarctic tunicate Synoicum adareanum. Journal of the American Chemical Society, 128, 5630-5631.
50. Conxita Avila, C., Taboada, S., Núñez-Pons, L. (2008). Antarctic marine chemical ecology: What is next? Marine Ecology, 29, 1-71.
51. Poulev, A., O'Neal, J.M., Logendra, S., Pouleva, R.B., Timeva, V., Garvey, A.S., Gleba, D., Jenkins, I.S., Halpern, B.T., Kneer, R., Cragg, G.M., Raskin, I. (2003). Elicitation, a new window into plant chemodiversity and phytochemical drug discovery. Journal of Medicinal Chemistry, 46, 2542-2547.
52. McCoy, E., O'Connor, S.E. (2006). Directed biosynthesis of alkaloid analogs in the medicinal plant. Catharanthus roseus. Journal of the American Chemical Society, 128, 14276-14277.
53. Pace, N.R. (1997). A molecular view of microbial diversity and the biosphere. Science, 276, 734-740.
54. Madigan, M.T., Martinko, J.M., Parker, J.B., Biology of Microorganisms, Prentice-Hall, Upper Saddle River, NJ, 1996.
55. Rappé, M.S., Giovannoni, S.J. (2003) The uncultured microbial majority. Annual Review of Microbiology, 57, 369-394.
56. McAlpine, J.B., Bachmann, B.O., Piraee, M., Tremblay, S., Alarco, A.-M., Zazopoulos, E., Farnet, C.M. (2005). Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example. Journal of Natural Products, 68, 493-496.
57. Lautru, S., Deeth, R.J., Bailey, L., Challis, G.M. (2005). Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nature Chemical Biology, 1, 265-269.
58. Park, E.Y. (2004). Recent progress in microbial cultivation techniques. Advances in Biochemical Engineering/Biotechnology, 90, 1-33.
59. Zengler, K., Toledo, G., Rappe, M., Elkins, J., Mathur, E.J., Short, J.M., Keller, M. (2002). Cultivating the unculture. Proceedings of the National Academy of Sciences of the USA, 99, 15681-15686.
60. Keller, M., Zengler, K. (2004). Tapping into microbial diversity. Nature Reviews Microbiology, 2, 141-150.
61. Stevenson, B.S., Eichorst, S.A., Wertz, J.T., Schmidt, T.M., Breznak, J.A. (2004). New strategies for cultivation and detection of previously uncultured microbes. Applied and Environmental Microbiology, 70, 4748-4755.
62. Nichols, D. Lewis, K.,Orjala, J.,Mo, S.,Ortenberg, R., O'Connor, P., Zhao, C.,Vouros, P., Kaeberlein, T., Epstein, S.S. (2008). Short peptide induces an "uncultivable" microorganism to grow in vitro. Applied and Environmental Microbiology, 74, 4889-4897.
63. Bollmann, A., Lewis, K., Epstein, S.S. (2007) Incubation of environmental samples in a diffusion chamber increases the diversity of recovered isolates. Applied and Environmental Microbiology, 73, 6386-6390.
64. Nichols, D., Cahoon, N., Trakhtenberg, E.M., Pham, L., Mehta, A., Belanger, A., Kanigan, T., Lewis, K., Epstein, S.S. (2010). High-throughput in situ cultivation of "uncultivable" microbial species. Applied and Environmental Microbiology, 76, 2445-2450.
65. Gontang, E.A., Fenical,W., Jensen, P.R. (2007). Phylogenetic diversity of gram-positive bacteria cultured from marine sediments. Applied and Environmental Microbiology, 73, 3272-3282.
66. Lefevre, F., Robe, P., Jarrin, C., Ginolhac, A., Zago, C., Auriol, D., Vogel, T.M., Simonet, P., Nalin, R. (2008). Drugs from hidden bugs: Their discovery via untapped resources. Research in Microbiology, 159, 153-161.
67. Wilkinson, B., Micklefield, J. (2007). Mining and engineering natural-product biosynthetic pathways. Nature Chemical Biology, 3, 379-386.
68. Rondon,M.R., August, P.R., Bettermann, A.D., Brady, S.F., Grossman, T.H., Liles,M.R., Loiacono, K.A., Lynch, B.A., MacNeil, I.A., Minor, C., Tiong, C.L., Gilman, M., Osburne, M.S., Clardy, J., Handelsman, J., Goodman, R.M. (2000). Cloning the soil metagenome: A strategy for accessing the genetic and functional diversity of uncultured microorganisms. Applied and EnvironmentalMicrobiology, 66, 2541-2547.
69. Venter, J.C., Remington, K., Heidelberg, J.F., Halpern, A.L., Rusch, D., Eisen, J.A., Wu, D., Paulsen, I., Nelson, K.E., Nelson, W., Fouts, D.E., Levy, S., Knap, A.H., Lomas, M.W., Nealson, K., White, O., Peterson, J., Hoffman, J., Parsons, R., Baden-Tillson, H., Pfannkoch, C., Rogers, Y.-H.,O., Smith, H.O. (2004). Environmental genome shotgun sequencing of the Sargasso Sea. Science, 304, 66-74.
70. Yooseph, S., Sutton, G., Rusch, D.B., Halpern, A.L., Williamson, S.J., Remington, K., Eisen, J.A., Heidelberg, K.B., Manning, G., Li, W., Jaroszewski, L., Cieplak, P., Miller, C.S., Li, H., Mashiyama, S.T., Joachimiak, M.P., van Belle, C., Chandonia, J.-M., Soergel, D.A., Zhai, Y., Natarajan, K., Lee, S., Raphael, B.J., Bafna, B., Friedman, R., Brenner, S.E., Godzik, A., Eisenberg, D., Dixon, J.E., Taylor, S.S., Strausberg, R.L., Frazier, M., Craig Venter, J. (2007). The Sorcerer II global ocean sampling expedition: Expanding the universe of protein families. PLoS Biology, 5, e16.
71. Warnecke, F., Luginb̈uhl, P., Ivanova, N., Ghassemian, M., Richardson, T.H., Stege, J.T., Cayouette, M., McHardy, A.C., Djordjevic, G., Aboushadi, N., Sorek, R., Tringe, S.G., Podar, M., Martin, H.G., Kunin, V., Dalevi, D., Madejska, J., Kirton, E., Platt, D., Szeto, E., Salamov, A., Barry, K., Mikhailova, N., Kyrpides, N.C., Matson, E.G., Ottesen, E.A., Zhang, X., Herńandez, M., Murillo, C., Acosta, L.G., Rigoutsos, I., Tamayo, G., Green, B.D., Chang, C., Rubin, E.M., Mathur, E.J., Robertson, D.E., Hugenholtz, P., Leadbetter, J.R. (2007). Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite. Nature, 450, 560-565.
72. Fieseler, L., Hentschel, U., Grozdanov, L., Schirmer, A., Wen, G., Platzer, M., Hrvatin, S., Butzke, D., Zimmermann, K., Piel, J. (2007). Widespread occurrence and genomic context of unusually small polyketide synthase genes in microbial consortia associated with marine sponges. Applied and Environmental Microbiology, 73, 2144-2155.
73. Vogel, T.M., Simonet, P., Jansson, J.K., Hirsch, P.R., Tiedje, J.M., van Elsas, J.D., Bailey, M.J., Nalin, R., Philippot, L. (2009). TerraGenome: A consortium for the sequencing of a soil metagenome. Nature Reviews Microbiology 7, 252.
74. van Elsas, J.D., Costa, R., Jansson, J., Sj̈oling, S., Bailey, M., Nalin, R., Vogel, T. M. van Overbeek, L. (2008). The metagenomics of disease-suppressive soils-Experiences from the METACONTROL project. Trends in Biotechnology, 26, 591-601.
75. Jin, M., Liu, L., Wright, S.A.I., Beer, S.V., Clardy, J. (2003). Structural and functional analysis of pantocin A: An antibiotic from Pantoea agglomerans discovered by heterologous expression of cloned genes. Angewandte Chemie International Edition, 42, 2898-2901.
76. Omura, S., Ikeda, H., Ishikawa, J., Hanamoto, A., Takahashi, C., Shinose, M., Takahashi, Y., Horikawa, H., Nakazawa, H., Osonoe, T., Kikuchi, H., Shiba, T., Sakaki, Y., Hattori, M. (2001). Genome sequence of an industrial microorganism Streptomyces avermitilis: Deducing the ability of producing secondary metabolites. Proceedings of the National Academy of Sciences of the U.S.A., 98, 12215-12220.
77. Ikeda, H., Ishikawa, J., Hanamoto, A., Shinose, M., Kikuchi, H., Shiba, T., Sakaki, Y., Hattori,M.,Omura,S. (2003).Complete genomesequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nature Biotechnology, 21, 526-531.
78. Bentley, S.D., Chater, K.F., Cerdeño-T́arraga, A.M., Challis, G.L., Thomson, N.R., James, K.D., Harris, D.E., Quail, M.A., Kieser, H., Harper, D., Bateman, A., Brown, S., Chandra, G., Chen, C.W., Collins, M., Cronin, A., Fraser, A., Goble, A., Hidalgo, J., Hornsby, T., Howarth, S., Huang, C.H., Kieser, T., Larke, L., Murphy, L., Oliver, K., O'Neil, S., Rabbinowitsch, E., Rajandream, M.A., Rutherford, K., Rutter, S., Seeger, K., Saunders, D., Sharp, S., Squares, R., Squares, S., Taylor, K., Warren, T., Wietzorrek, A., Woodward, J., Barrell, B.G., Parkhill, J., Hopwood, D.A. (2002). Complete genome sequenceofthemodelactinomyceteStreptomycescoelicolor A3(2).Nature,417,141-147.
79. Banskota, A.H., McAlpine, J.B., Sørensen, D., Ibrahim, A., Aouidate, M., Piraee, M., Alarco, A.M., Farnet, C.M., Zazopoulos, E. (2006). Genomic analyses lead to novel secondary metabolites. Journal of Antibiotics, 59, 533-542.
80. Gourdeau, H., McAlpine, J.B., Ranger, M., Simard, B., Berger, F., Beaudry, F., Farnet, C. M., Falardeau, P. (2008). Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand. Cancer Chemotherapy and Pharmacology, 61, 911-921.
81. Rachid, S., Gerth, K., Kochems, I., M̈uller, R. (2007). Deciphering regulatory mechanisms for secondary metabolite production in the myxobacterium Sorangium cellulosum So ce56. Molecular Microbiology, 63, 1783-1796.
82. Weissman, K.J.,M̈uller, R. (2009).Abrief tour of myxobacterial secondary metabolism. Bioorganic and Medicinal Chemistry, 17, 2121-2136.
83. Bok, J.W., Hoffmeister, D., Maggio-Hall, L.A., Murillo, R., Glasner, J.D., Keller, N.P. (2006). Genomic mining for Aspergillus natural products. Chemical Biology, 13, 31-37.
84. Hoffmeister, D., Keller, N.P. (2007). Natural products of filamentous fungi: Enzymes, genes, and their regulation. Natural Products Reports, 24, 393-416.
85. Olano, C., Ḿendez, C., Salas, J.A. (2009) Antitumor compounds from marine actinomycetes. Marine Drugs, 7, 210-248.
86. Mincer, T.J., Jensen, P.R., Kauffman, C.A., Fenical, W. (2002). Widespread and persistent populations of a major new marine Actinomycete taxon in ocean sediments. Applied and Environmental Microbiology, 68, 5005-5011.
87. Udwary, D.W., Zeigler, L., Asolkar, R.N., Singan, V., Lapidus, A., Fenical, W., Jensen, P.R., Moore, B.S. (2007). Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proceedings of the National Academy of Sciences of the U.S.A., 104, 10376-10381.
88. Feling, R.H., Buchanan, G.O., Mincer, T.J., Kauffman, C.A., Jensen, P.R., Fenical, W. (2003) Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angewandte Chemie International Edition, 42, 355-357.
89. Fenical, W., Jensen, P.R., Palladino, M.A., Lam, K.S., Lloyd, G.K., Potts, B.C. (2009). Discovery and development of the anticancer agent salinosporamide A (NPI-0052). Bioorganic and Medicinal Chemistry, 17, 2175-2180.
90. Potts, B.C., Lam, K.S. (2010). Generating a generation of proteasome inhibitors: From microbial fermentation to total synthesis of salinosporamide A (Marizomib) and other salinosporamides. Marine Drugs, 8, 835-880.
91. Kwon, H.C., Kauffman, C.A., Jensen, P.R., Fenical, W. (2006) Marinomycins A-D, antitumor-antibiotics of a newstructure class from a marine actinomycete of the recently discovered genus "Marinispora. " Journal of the American Chemical Society, 128, 1622-1632.
92. Williams, P.G., Asolkar, R.N., Kondratyuk, T., Pezzuto, J.M., Jensen, P.R., Fenical, W. (2007) Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. Journal of Natural Products, 70, 83-88.
93. Oh, D.C., Strangman, W.K., Kauffman, C.A., Jensen, P.R., Fenical, W. (2007). Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassospira sp. Organic Letters, 9, 1525-1528.
94. Bredholt, H., Fjærvik, E., Johnsen, G., Zotchev, S.B. (2008). Actinomycetes from sediments in the Trondheim Fjord, Norway: Diversity and biological activity. Marine Drugs, 6, 12-24.
95. Welker, M., von D̈ohren, H. (2006). Cyanobacterial peptides-Nature's own combinatorial biosynthesis. FEMS Microbiology Reviews, 30, 530-563.
96. Tan, L.T. (2007) Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry, 68, 954-979.
97. Tidgewell, K., Clark, B.R., Gerwick, W.H., The natural products chemistry of cyanobacteria. In: Mander, L., and Liu, H.-W.editors. Comprehensive Natural Products Chemistry. Chemistry and Biology, Vol. 2 Elsevier Ltd., Oxford, 2010, pp. 141-188.
98. Al-awar, R.S., Sih, C., The isolation, characterization, and development of a novel class of potent antitumor macrocyclic depsipeptides: The cryptophcins. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 151-170.
99. Magarvey, N.A., Beck, Z.Q., Golakoti, T., Ding, Y., Huber, U., Hemscheidt, T.K., Abelson, D., Moore, R.E., Sherman, D.H. (2006). Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from Nostoc cyanobionts. ACS Chemical Biology, 1, 766-779.
100. Chang, Z., Sitachitta, N., Rossi, J.V., Roberts, M.A., Flatt, P.M., Jia, J., Sherman, D.H., Gerwick,W.H. (2004). Biosynthetic pathway and gene cluster analysis of curacin A, an anti-tubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula. Journal of Natural Products, 67, 1356-1367.
101. Esquenazi, E., Coates, C., Simmons, L., Gonzalez, D., Gerwick, W.H., Dorrestein, P.C. (2008).Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging. Molecular BioSystems. Molecular BioSystems, 4, 562-570.
102. Jones, A.C., Gerwick, L., Gonzalez, D., Dorrestein, P.C., Gerwick, W.H. (2009). Transcriptional analysis of the jamaicamide gene cluster from the marine cyanobacterium Lyngbya majuscula and identification of possible regulatory proteins. BMC Microbiology, 9, 247.
103. Sattely, E.S., Fischbach, M.A., Walsh, C.T. (2008). Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Natural Products Reports, 25, 757-793.
104. Piel, J. (2004). Metabolites from symbiotic bacteria. Natural Products Reports, 21, 519-538.
105. Thomas, T.R.A., Kavlekar, D.P., LokaBharathi, P.A. (2010). Marine drugs from sponge-microbe association-A review. Marine Drugs, 8, 1417-1468.
106. Penesyan, A., Kjelleberg, S., Egan, S. (2010). Development of novel drugs from marine surface associated microorganisms. Marine Drugs, 8, 438-459.
107. Piel, J. (2009). Metabolites from symbiotic bacteria. Natural Products Reports, 26, 338-362.
108. Yu, T.-W., Floss, H.G., Ansamitocins (maytansinoids). In: Cragg, G.M., Kingston, D.G. I., and Newman, D.J.editors. Anticancer Agents from Natural Products, Taylor and Francis, Boca Raton, FL, 2005, pp. 321-337.
109. Piel, J., Butzke, D., Fusetani, N., Hui, D., Platzer, M., Wen, G., Matsunaga, S. (2005). Exploring the chemistry of uncultivated bacterial symbionts: Antitumor polyketides of the pederin family. Journal of Natural Products, 68, 472-479.
110. Piel, J.; Hofer, I., Hui, D. (2004). Evidence for a symbiosis island involved in horizontal acquisition of pederin biosynthetic capabilities by the bacterial symbiont of Paederus fuscipes beetles. Journal of Bacteriology, 186, 1280-1286.
111. Piel, J., Hui, D., Wen, G., Butzke, D., Platzer, M., Fusetani, N., Matsunaga, S. (2004). Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei. Proceedings of the National Academy of Sciences of the U.S. A., 101, 16222-16227.
112. Zimmermann, K., Engeser, M., Blunt, J.W., Munro, M.H., Piel, J. (2009). Pederin-type pathways of uncultivated bacterial symbionts: Analysis of o-methyltransferases and generation of a biosynthetic hybrid. Journal of the American Chemical Society, 131, 2780-2781.
113. Partida-Martinez, L.P., Hertweck, C. (2005). Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature, 437, 884-888.
114. Partida-Martinez, L.P., Hertweck, C. (2007). A gene cluster encoding rhizoxin biosynthesis in "Burkholderia rhizoxina," the bacterial endosymbiont of the fungus Rhizopus microsporus. ChemBioChem, 8, 41-45.
115. Uria, A., Piel, J. (2009). Cultivation-independent approaches to investigate the chemistry of marine symbiotic bacteria. Phytochemistry Reviews, 8, 401-414.
116. Hertweck, C. (2009). Hidden biosynthetic treasures brought to light. Nature Chemical Biology, 5, 450-452.
117. Gunatilaka, A.A.L. (2006). Natural products from plant-associated microorganisms: Distribution, structural diversity, bioactivity, and implications of their occurrence. Journal of Natural Products, 69, 509-526.
118. Strobel, G., Daisy, B., Castillo, U., Harper, J. (2004). Natural products from endophytic microorganisms. Journal of Natural Products, 67, 257-268.
119. Tan, R.X., Zou, W.X. (2001). Endophytes: A rich source of functional metabolites. Natural Products Reports, 18, 448-459.
120. Castillo, U., Harper, J.K., Strobel, G.A., Sears, J., Alesi, K., Ford, E., Lin, J., Hunter, M., Maranta, M., Ge, H., Yaver, D., Jensen, J.B., Porter, H., Robinson, R., Millar, D., Hess, W.M., Condron, M., Teplow, D. (2003). Kakadumycins, novel antibiotics from Streptomyces sp. NRRL 30566, an endophyte of Grevillea pteridifolia. FEMS Microbiology Letters, 224, 183-190.
121. Li, J.Y., Harper, J.K., Grant, D.M., Tombe, B.O., Bashyal, B., Hess,W.M., Strobel, G.A. (2001). Ambuic acid, a highly functionalized cyclohexenone with antifungal activity from Pestalotiopsis spp. and Monochaetia sp. Phytochemistry, 56, 463-468.
122. Ezra, D., Castillo, U.F., Strobel, G.A., Hess, W.M., Porter, H., Jensen, J.B., Condron, M.A., Teplow, D.B., Sears, J., Maranta, M., Hunter, M., Weber, B., Yaver, D. (2004). Coronamycins, peptide antibiotics produced by a verticillate Streptomyces s. (MSU-2110) endophytic on Monstera sp. Microbiology, 150, 785-793.
123. Zhou, G.-X., Wijeratne, E.M.K., Bigelow, D., PiersonIII, L.S., VanEtten, H.D., Gunatilaka, A.A.L. (2004). Aspochalasins I, J, and K: Three new cytotoxic cytochalasans of Aspergillus flavipes from the rhizosphere of Ericameria laricifolia of the Sonoran desert. Journal of Natural Products, 67, 328-332.
124. Stierle, A., Strobel, G., Stierle, D. (1993). Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of Pacific yew. Science, 260, 214-216.
125. Li, J.-Y., Sidhu, R.S., Bollon, A., Strobel, G.A. (1998). Stimulation of taxol production in liquid cultures of Pestalotiopsis microspora. Mycology Research, 102, 461-464.
126. Puri, S.C., Verma, V., Amna, T., Qazi, G.N., Spiteller,M. (2005). An endophytic fungus from Nothapodytes foetida that produces camptothecin. Journal of Natural Products, 68, 1717-1719.
127. Amna, T., Puri, S.C., Verma, V., Sharma, J.P., Khajuria, R.K., Musarrat, J., Spiteller, M., Qazi, G.N. (2006). Bioreactor studies on the endophytic fungus Entrophosphora infrequens for the production of an anticancer alkaloid camptothecin. Canadian Journal of Microbiology, 52, 189-196.
128. Eyberger, A.L., Dondapati, R., Porter, J.R. (2006). Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin. Journal of Natural Products, 69, 1121-1124.
129. Puri, S.C., Nazir, A., Chawla, R., Arora, R., Riyaz-ul-Hasan, S., Amna, T., Ahmed, B., Verma, V., Singh, S., Sagar, R., Sharma, A., Kumar, R., Sharma, R.K., Qazi, G.N. (2006). The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related tetralin lignans. Journal of Biotechnology, 122, 494-510.
130. Guo, B., Li, H., Zhang, L. (1998). Isolation of a fungus producing vinblastine. Journal of Yunnan University, 20, 214-215.
131. Zhang, L.Q., Guo, B., Li, H., Zeng, S., Shao, H., Gu, S., Wei, R. (2000). Preliminary study on the isolation of an endophytic fungus of Catharanthus roseus and its fermentation to produce products of therapeutic value. Zhong Cao Yao (Chinese Traditional and Herbal Drugs), 31, 805-807.
132. Yang, X., Zhang, L., Guo, B., Guo, S. (2004). Preliminary study of a vincristineproducing endophytic fungus isolated from leaves of Catharanthus roseus. Zhong Cao Yao (Chinese Traditional and Herbal Drugs), 35, 79-81.
133. Abe, F., Horikoshi, K. (2001). The biotechnological potential of piezophiles. Trends in Biotechnology, 19, 102-108.
134. Persidis, A. (1998). Extremophiles. Nature Biotechnology, 16, 593-594.
135. Rossi, M., Ciaramella, M., Cannio, R., Pisani, F.M., Moracci, M., Bartolucci, S. (2003). Extremophiles 2002. Journal of Bacteriology, 185, 3683-3689.
136. Jørgensen, B.B., Boetius, A. (2007). Feast and famine-Microbial life in the deep-sea bed. Nature Reviews Microbiology, 5, 770-781.
137. Pikuta, E.V., Hoover, R.B., Tang, J. (2007). Microbial extremophiles at the limits of life. Critical Reviews in Microbiology, 33, 183-209.
138. Wagner, I.D.,Wiegel, J. (2008). Diversity of thermophilic anaerobes. Annals of the New York Academy of Sciences, 1125, 1-43.
139. Cavicchioli, R., Siddiqui, K.S., Andrews, D., Sowers, K.R. (2002). Lowtemperature extremophiles and their applications. Current Opinion in Biotechnology, 13, 253-261.
140. Feller, G. (2003). Psychrophilic enzymes: Hot topics in cold adaptation. Nature Reviews Microbiology, 1, 200-208.
141. Cavicchioli , R. (2006). Cold-adapted archaea. Nature ReviewsMicrobiology, 4, 331-343.
142. Gomes, J., Steiner, W. (2004). The biocatalytic potential of extremophiles and extremozymes. Food Technology and Biotechnology, 42, 223-235.
143. Hoyoux, A., Blaise, V., Collins, T., D'Amico, S., Gratia, E., Huston, A.L., Marx, J.C., Sonan, G., Zeng, Y.X., Feller, G., Gerday, C. (2004). Extreme catalysts from lowtemperature environments. Journal of Bioscience and Bioengineering, 98, 317-330.
144. Schiraldi, C., De Rosa, M. (2002). The production of biocatalysts and biomolecules from extremophiles. Trends in Biotechnology, 20, 515-521.
145. van den Burg, B. (2003). Extremophiles as a source for novel enzymes. Current Opinion in Microbiology, 6, 213-218.
146. Pettit, R.K. (2010). Culturability and secondary metabolite diversity of extreme microbes: Expanding contribution of deep sea and deep-sea vent microbes to natural product discovery. Marine Biotechnology, 13, 1-11.
147. Wilson, Z.E., Brimble, M.A. (2009). Molecules derived from the extremes of life. Natural Products Reports, 26, 44-71.
148. Johnson, D.B., Hallberg, K.B. (2003). The microbiology of acidic mine waters. Research in Microbiology, 154, 466-473.
149. Stierle, A.A., Stierle, D.B., Kemp, K. (2004). Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile. Journal of Natural Products, 67, 1392-1395.
150. Stierle, D.B., Stierle, A.A., Hobbs, D., Stokken, J., Clardy, J. (2004). Berkeleydione and berkeleytrione, newbioactive metabolites from an acid mine organism. Organic Letters, 6, 1049-1052.
151. Stierle, A.A., Stierle, D.B., Patacini, B. (2008). The berkeleyamides, amides from the acid lake fungus Penicillum rubrum. Journal of Natural Products, 71, 856-860.
152. Park, H.B., Kwon, H.C., Lee, C. -H, Yang, H.O. (2009). Glionitrin A, an antibiotic-antitumor metabolite derived from competitive interaction between abandoned mine microbes. Journal of Natural Products, 72, 248-252.
153. Li Y., Ye D., Chen X., Lu X., Shao Z., Zhang H., Che Y. (2009). Breviane spiroditerpenoids from an extreme-tolerant Penicillium sp. isolated from a deep sea sediment sample. Journal of Natural Products, 72, 912-916.
154. Du, L., Li, D., Zhu, T., Cai, S., Wang, F., Xiao, X., Gu, Q. (2009). New alkaloids and diterpenes from a deep ocean sediment derived fungus Penicillium sp. Tetrahedron, 65, 1033-1039.
155. Khosla, C. (2000). Natural product biosynthesis: A new interface between enzymology and medicine. Journal of Organic Chemistry, 65, 8127-8133.
156. Staunton, J., Weissman, K.J. (2001). Polyketide biosynthesis: A millennium review. Natural Products. Reports, 18, 380-416.
157. Walsh, C.T. (2004). Polyketide and nonribosomal peptide antibiotics: Modularity and versatility. Science, 303, 1805-1810.
158. Van Lanen, S.G., Shen, B. (2006). Microbial genomics for the improvement of natural product discovery. Current Opinion in Microbiology, 9, 252-260.
159. Abhirup Das, A., Khosla, C. (2009). Biosynthesis of aromatic polyketides in bacteria. Accounts of Chemical Research, 42, 631-639.
160. Kopp, F., Marahiel, M.A. (2007). Where chemistry meets biology: The chemoenzymatic synthesis of nonribosomal peptides and polyketides. Current Opinion in Biotechnology, 18, 513-520.
161. Walsh, C.T. (2008). The chemical versatility of natural-product assembly lines. Accounts of Chemical Research, 41, 4-10.
162. Sattely, E.S., Fischbach, M.A., Walsh, C.T. (2008). Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Natural Products Reports, 25, 757-793.
163. Weissman, K.J., M̈uller, R. (2008). Protein-protein interactions in multienzyme megasynthetases. ChemBioChem, 9, 826-848.
164. Felnagle, E.A., Jackson, E.E., Yolande A. Chan, Y.A., Angela, M., Podevels, A.M., Andrew, D., Berti, A.D., Matthew, D., McMahon, M.D., Thomas, M.G. (2008). Nonribosomal peptide synthetases involved in the production of medically relevant natural products. Molecular Pharmaceutics, 5, 191-211.
165. Marahiel, M.A., Essen, L.-O., Nonribosomal peptide synthetases: Mechanistic and structural aspects of essential domains. In: Hopwood, D.A., editor. Methods in Enzymology. Complex Enzymes in Microbial Natural Product Biosynthesis, Part A: Overview Articles and Peptides. Elsevier, Inc., Oxford, 2009, pp. 337-351.
166. Koglin, A.,Walsh, C.T. (2009). Highlight: Structural insights into nonribosomal peptide enzymatic assembly lines. Natural Products Reports, 26, 987-1000.
167. Nolan, E.M.,Walsh, C.T. (2009). How nature morphs peptide scaffolds into antibiotics. ChemBioChem, 10, 34-53.
168. Clardy, J., Walsh, C.T. (2004). Lessons from natural molecules. Nature, 432, 829-837.
169. Kira J.,Weissman, K.J. (2007). Mutasynthesis-Uniting chemistry and genetics for drug discovery. Trends in Biotechnology, 25, 139-142.
170. Thomas, M.G., Bixby, K.A., Shen, B., Combinatorial biosynthesis of anticancer natural molecules. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, Taylor & Francis, Boca Raton, FL, 2005, pp. 519-552.
171. Wenzel, S.C., M̈uller, R. (2009). The biosynthetic potential of myxobacteria and their impact in drug discovery. Current Opinion in Drug Discovery and Development, 12, 220-230.
172. Tang, L., Chung, L., Carney, J.R., Starks, C.M., Licari, P., Katz, L. (2005). Generation of new epothilones by genetic engineering of a polyketide synthase in Myxococcus xanthus. Journal of Antibiotics, 58, 178-184.
173. Chou, T.C., Zhang, X., Zhong, Z.Y., Li, Y., Feng, L., Eng, S., Myles, D.R., Johnson, R., Wu, N., Yin, Y.I., Wilson, R.M., Danishefsky, S.J. (2008). Therapeutic effect against human xenograft tumors in nude mice by the third generation microtubule stabilizing epothilones. Proceedings of the National Academy of Sciences of the U.S.A., 105, 13157-13162.
174. Julien, B., Shah, S., Ziemann, R., Goldman, R., Katz, L., Khosla, C. (2000). Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum. Gene, 249, 153-160.
175. Molnar, I., Schupp, T., Ono, M., Zirkle, R.E., Milnamow, M., Nowak-Thompson, B., Engel, N., Toupet, C., Stratmann, A., Cyr, D.D., Gorlach, J., Mayo, J.M., Hu, A., Goff, S., Schmid, J., Ligon, J.M. (2000). The biosynthetic gene cluster for the microtubulestabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chemical Biology, 7, 97-109.
176. Lau, J., Frykman, S., Regentin, R., Ou, S., Tsuruta, H., Licari, P. (2002). Optimizing the heterologous production of epothilone D in Myxococcus xanthus. Biotechnology and Bioengineering, 78, 280-288.
177. Evans, B.E., Rittle, K.E., Bock, M.G., DiPardo, R.M., Freidinger, R.M., Whitter, W.L., Lundell, G.F., Veber, D.F., Anderson, P.S., Chang, R.S.L., Lotti, V.J., Cerino, D.J., Chen, T.B., Kling, P.J., Kunkel, K.A., Springer, J.P., Hirshfield, J. (1988). Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists. Journal of Medicinal Chemistry, 31, 2235-2246.
178. Kingston, D.G.I., Taxol and its analogs. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J., editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 89-122.
179. Kingston, D.G.I. (2008). A natural love of natural products. Journal of Organic Chemistry, 73, 3975-3984.
180. Rahier, N.J., Thomas, C.J., Hecht, S.M., Camptothecin and its analogs. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J. editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 5-22.
181. Pinney, K.G., Jelinek, C., Edvardsen, K., Chaplin, D.J. Pettit, G.R., The discovery and development of the combretastatins. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J.editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 23-46.
182. Rinehart, K.L., Holt, T.G., Fregeau, N.L., Stroh, J.G., Keifer, P.A., Sun, F., Li, L.H., Martin, D.G. (1990). Ecteinascidins 729, 743, 745, 759A and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. Journal of Organic Chemistry, 55, 4512-4515.
183. Wright, A.E., Forleo, D.A., Gunawardana, G.P., Gunasekera, S.P., Koehn, F.E., McConnell, O.J. (1990). Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata. Journal of Organic Chemistry, 55, 4508-4512.
184. Cuevas, C., Ṕerez, M., Martín, M.J., Chicharro, J.L., Fernández-Rivas, C., Flores, M., Francesch, A.M., Gallego, P., Zarzuelo, M., de La Calle, F., García, J., Polanco, C., Rodríguez, I., Manzanares, I. (2000). Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Organic Letters, 2, 2545-2548.
185. Newman, D.J., Cragg, G.M. (2006). Natural products from marine invertebrates and microbes as modulators of antitumor targets. Current Drug Targets, 7, 279-304.
186. Nicolaou, K.C., Vourloumis, D.,Winssinger, N., Baran, P.S. (2000). The art and science of total synthesis at the dawn of the twenty-first century. Angewandte Chemie International Edition, 39, 44-122.
187. Mickel, S.J., Niederer, D., Daeffler, R., Osmani, A., Kuesters, E., Schmid, E., Schaer, K., Gamboni, R., Chen, W.C., Loeser, E., Kinder, F.R., Jr., Konigsberger, K., Prasad, K., Ramsey, T.M., Repic, O., Wang, R.M., Florence, G., Lyothier, I., Paterson, I. (2004) Large-scale synthesis of the anti-cancer marine natural product ({thorn})-discodermolide. Part 5: Linkage of fragments C1-6 and C7-24 and finale. Organic Process Research and Development, 8, 122-130.
188. Freemantle, M., (2004). Discodermolide. Chemical and Engineering News, 82, 33-35.
189. Njardarson, J.T., Gaul, C., Shan, D.; Huang, X.Y., Danishefsky, S.J. (2004). Discovery of potent cell migration inhibitors through total synthesis: Lessons from structure-activity studies of ({thorn})-migrastatin. Journal of the American Chemical Society, 126, 1038-1040.
190. Wilson, R.M., Danishefsky, S.J. (2006). Small molecule natural products in the discovery of therapeutic agents: The synthesis connection. Journal of Organic Chemistry, 71, 8329-8351.
191. http://www.bloomberg.com/news/2010-06-02/eisai-s-eribulin-breast-cancer-treatmentgets-priority-review-by-u-s-fda.html.
192. Flahive, E., Srirangam, J., The dolastatins. Novel antitumor agents from Dollabella auricularia. In: Cragg, G.M., Kingston, D.G.I., and Newman, D.J.editors. Anticancer Agents from Natural Products, CRC Press, Boca Raton, FL, 2005, pp. 191-214.
193. Law, C.-L., Gordon, K.A., Toki, B.E., Yamane, A.K., Hering, M.A., Cerveny, C.G., Petroziello, J.M., Ryan, M.C., Smith, L., Simon, R., Sauter, G., Oflazoglu, E., Doronina, S.O., Meyer, D.L., Francisco, J.A., Carter, P., Senter, P.D., Copland, J.A., Wood, C.G.,Wahl, A.F. (2006). Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. Cancer Research, 66, 2328-2337.
194. Sutherland, M.S.K., Sanderson, R.J., Gordon, K.A., Andreyka, J., Cerveny, C.G.,Yu, C., Lewis, T.S., Meyer, D.L., Zabinski, R.F., Doronina, S.O., Senter, P.D., Law, C.-L., Wahl, A.F. (2006). Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates. Journal of Biological Chemistry, 281, 10540-10547.
195. Oflazoglu, E., Kissler, K.M., Sievers, E.L., Grewal, I.S., Gerber, H.-P. (2008). Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma. British Journal of Haematology, 142, 69-73.
196. Pollack, V.A., Alvarez, E., Tse, K.F., Torgov, M.Y., Xie, S., Shenoy, S.G., MacDougall, J.R., Arrol, S., Zhong, Z., Gerwein, R.W., Hahne, W.F., Senter, P.D., Jeffers, M.E., Lichtenstein, H.S., LaRochelle, W.J. (2007). Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB. Cancer Chemotherapy and Pharmacology, 60, 423-435.
197. Ma, D., Hopf, C.E., Malewicz, A.D., Donovan, G.P., Senter, P.D., Goeckeler, W.F., Maddon, P.J., Olson,W.C. (2006). Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen. Clinical Cancer Research, 12, 2591-2596.
198. Borman, S. (2003). The many faces of combinatorial chemistry. Chemical and Engineering News, 81, 45-56.
199. Class, S. (2002). Pharma overview. Chemical and Engineering News, 80, 39-49.
200. Breinbauer, R., Manger, M., Scheck, M.,Waldmann, H. (2002). Natural product guided compound library development. Current Medicinal Chemistry, 9, 2129-2145.
201. Breinbauer, R., Vetter, I.R., Waldmann, H. (2002). From protein domains to drug candidates-Natural products as guiding principles in the design and synthesis of compound libraries. Angewandte Chemie International Edition, 41, 2878-2890.
202. Kaiser, M.,Wetzel, S., Kumar, K.,Waldmann, H. (2008). Biology-inspired synthesis of compound libraries. Cellular and Molecular Life Sciences, 65, 1186-1201.
203. Burke, M.D., Berger, E.M., Schreiber, S.L. (2003). Generating diverse skeletons of small molecules combinatorially. Science, 302, 613-618.
204. Burke, M.D., Schreiber, S.L. (2004). A planning strategy for diversity-oriented synthesis. Angewandte Chemie International Edition, 43, 46-58.
205. Burke, M.D., Berger, E.M., Schreiber, S.L. (2004). A synthesis strategy yielding skeletally diverse small molecules combinatorially. Journal of the American Chemical Society, 126, 14095-14104.
206. Nielsen, T.E., Schreiber, S.L. (2008). Towards the optimal screening collection: A synthesis strategy. Angewandte Chemie International Edition, 47, 48-56.
207. Nicolaou, K.C., Pfefferkorn, J.A., Roecker, A.J., Cao, G.Q., Barluenga, S., Mitchell, H.J. (2000). Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. Journal of the American Chemical Society, 122, 9939-9953.
208. Nicolaou, K.C., Kim, S., Pfefferkorn, J., Xu, J., Ohshima, T., Hosokawa, S., Vourloumis, D., Li, T. (1998). Synthesis and biological activity of sarcodictyins. Angewandte Chemie International Edition, 37, 1418-1421.
209. Thutewohl, M., Kissau, L., Popkirova, B., Karaguni, I.M., Nowak, T., Bate, M., Kuhlmann, J., M̈uller, O., Waldmann, H. (2002). Solid-phase synthesis and biological evaluation of a pepticinnamin E library. Angewandte Chemie International Edition, 41, 3616-3620.
210. Nicolaou, K.C., Roschangar, F., Vourloumis, D. (1998). Chemical biology of epothilones. Angewandte Chemie International Edition, 37, 2014-2045.
211. Nicolaou, K.C., Hughes, R., Cho, S.Y.,Winssinger, N., Labischinski, H., Endermann, R. (2001). Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: Target-accelerated combinatorial synthesis. Chemistry-A European Journal, 7, 3824-3843.
212. Wipf, P., Reeves, J.T., Balachandran, R., Giuliano, K.A., Hamel, E., Day, B.W. (2000). Synthesis and biological evaluation of a focused mixture library of analogues of the antimitotic marine natural product curacin A. Journal of the American Chemical Society, 122, 9391-9395.
213. Nicolaou, K.C., Pfefferkorn, J.A., Barluenga, S., Mitchell, H.J., Roecker, A.J., Cao, G.Q. (2000). Natural product-like combinatorial libraries based on privileged structures. 3. The "libraries from libraries" principle for diversity enhancement of benzopyran libraries. Journal of the American Chemical Society, 122, 9968-9976.
214. Nicolaou, K.C., Pfefferkorn, J.A., Mitchell, H.J., Roecker, A.J., Barluenga, S., Cao, G.Q., Affleck, R.L., Lillig, J.E. (2000). Natural product-like combinatorial libraries based on privileged structure. 2. Construction of a 10000-membered benzopyran library by directed split-and-pool chemistry using nanokans and optical encoding. Journal of the American Chemical Society, 122, 9954-9967.
215. Koonin, E.V., Wolf, Y.I., Karev, G.P. (2002). The structure of the protein universe and genome evolution. Nature, 420, 218-223.
216. Koch, M.A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P.; Waldmann, H. (2005). Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proceedings of the National Academy of Sciences of the U.S.A., 102, 17272-17277.
217. Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M.A., Waldmann, H. (2007). The Scaffold Tree-Visualization of the scaffold universe by hierarchical scaffold classification. Journal of Chemical Information and Modeling, 47, 47-58.
218. Dekker, F.J., Koch, M.A., Waldmann, H. (2005). Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics. Current Opinion in Chemical Biology, 9, 232-239.
219. Koch, M.A., Breinbauer, R., Waldmann, H. (2003). Protein structure similarity as guiding principle for combinatorial library design. Biological Chemistry, 384, 1265-1272.
220. Koch, M.A., Waldmann, H. (2005). Protein structure similarity clustering and natural product structure as guiding principles in drug discovery. Drug Discovery Today, 10, 471-483.
221. Brohm, D., Metzger, S., Bhargava, A., M̈uller, O., Lieb, F., Waldmann, H. (2002). Natural products are biologically validated starting points in structural space for compound library development: Solid-phase synthesis of dysidiolide-derived phosphatase inhibitors. Angewandte Chemie International Edition, 41, 307-311.
222. Koch, M.A.,Wittenberg, L.O., Basu, S., Jeyaraj, D.A., Gourzoulidou, E., Reinecke, K., Odermatt, A.,Waldmann, H. (2004). Compound library development guided by protein structure similarity clustering and natural product structure. Proceedings of the National Academy of Sciences of the U.S.A., 101, 16721-16726.
223. Kobayashi, J., Madono, T., Shigemori, H. (1995). Nakijiquinones C and D, new sesquiterpenoid quinones with a hydroxy amino acid residue from a marine sponge inhibiting c-erbB-2 kinase. Tetrahedron, 51, 10867-10874.
224. Stahl, P., Kissau, L., Mazitschek, R., Giannis, A., Waldmann, H. (2002). Natural product derived receptor tyrosine kinase inhibitors: Identification of IGF1R, Tie-2, and VEGFR-3 inhibitors. Angewandte Chemie International Edition, 41, 1174-1178.
225. Kissau, L., Stahl, P., Mazitschek, R., Giannis, A., Waldmann, H. (2003). Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold. Journal of Medicinal Chemistry, 46, 2917-2931.
226. Klekota, J., Brauner, E., Roth, F.P., Schreiber, S.L. (2006). Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects. Journal of Chemical Information and Modeling, 46, 1549-1562.
227. Spring, D.R. (2003). Diversity-oriented synthesis; a challenge for synthetic chemists. Organic and Biomolecular Chemistry, 1, 3867-3870.
228. Spandl, R.J., Díaz-Gaviĺan, M., O'Connell, K.M., Thomas, G.L., Spring, D.R. (2008). Diversity-oriented synthesis. Chemical Record, 8, 129-142.
229. Spandl, R.J., Bender, A., Spring, D.R. (2008). Diversity-oriented synthesis; a spectrum of approaches and results. Organic and Biomolecular Chemistry, 6, 1149-1158.
230. Peuchmaur, M.,Wong,Y.S. (2008). Expanding the chemical space in practice: Diversityoriented synthesis. Combinatorial Chemistry and High Throughput Screening, 11, 587-601.
231. Cordier, C., Morton, D., Murrison, S., Nelson, A., O'Leary-Steele, C. (2008). Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries. Natural Products Reports, 25, 719-737.
232. Walsh, D.P., Chang, Y.T. (2006). Chemical genetics. Chemical Reviews, 106, 2476-2530.
233. Morton, D., Leach, S., Cordier, C.,Warriner, S., Nelson, A. (2009). Synthesis of naturalproduct-like molecules with over eighty distinct scaffolds. Angewandte Chemie International Edition, 48, 104-109.
234. Pelish, H.E., Westwood, N.J., Feng, Y., Kirchhausen, T., Shair, M.D. (2001). Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. Journal of the American Chemical Society, 123, 6740-6741.
235. Blackwell, H.E., Ṕerez, L., Stavenger, R.A., Tallarico, J.A., Cope Eatough, E., Foley, M.A., Schreiber, S.L. (2001). A one-bead, one-stock solution approach to chemical genetics: Part 1. Chemical Biology, 8, 1167-1182.
236. Clemons, P.A., Koehler, A.N.,Wagner, B.K., Sprigings, T.G., Spring, D.R., King, R.W., Schreiber, S.L., Foley, M.A. (2001). A one-bead, one-stock solution approach to chemical genetics: Part 2. Chemical Biology, 8, 1183-1195.
237. Koehler, A.N., Shamji, A.F., Schreiber, S.L. (2003). Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. Journal of the American Chemical Society, 125, 8420-8421.
238. A Second Edition of Anticancer Agents from Natural Products was published in November 2011 and readers may refer to this edition for the latest information discussed in references 29-31; 34-39; 96, 106, 168, 176, 178-9; 190.